Anthony Dobranowski
Directeur/Bestuurslid bij CRESCITA THERAPEUTICS INC.
Vermogen: 31 900 $ op 31-05-2024
Actieve functies van Anthony Dobranowski
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CRESCITA THERAPEUTICS INC. | Directeur/Bestuurslid | 01-03-2016 | - |
| Independent Dir/Board Member | 01-03-2016 | - |
Loopbaan van Anthony Dobranowski
Eerdere bekende functies van Anthony Dobranowski
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NUVO PHARMACEUTICALS INC. | Directeur/Bestuurslid | 21-09-2004 | 01-03-2023 |
| Independent Dir/Board Member | 13-12-2011 | 01-03-2023 | |
| MAGNA INTERNATIONAL INC. | Corporate Officer/Principal | 01-01-2005 | 01-09-2007 |
Tesma International, Inc.
 Tesma International, Inc. Auto Parts: OEMProducer Manufacturing Tesma International, Inc. is used to manufacture engine, transmission and fueling components. Its engine productsuesd to include oil and water pumps, as well as pulleys and tensioners. Its transmission systems uesd to include torque converters and clutch housings. Its offerings uesd to include cap-to-tank refueling modules. It was located in Concord, Canada | Directeur/Bestuurslid | 01-01-1995 | - |
| Financieel Directeur/CFO | 01-01-1995 | - | |
| President | 01-01-1995 | - | |
| Heating Oil Partners Income Fund | Directeur/Bestuurslid | - | - |
Opleiding van Anthony Dobranowski
| University of Toronto | Masters Business Admin |
Statistieken
Internationaal
| Canada | 7 |
Operationeel
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
| Masters Business Admin | 1 |
Sectoraal
| Health Technology | 3 |
| Producer Manufacturing | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MAGNA INTERNATIONAL INC. | Producer Manufacturing |
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
| Heating Oil Partners Income Fund | Miscellaneous |
Tesma International, Inc.
Tesma International, Inc. Auto Parts: OEMProducer Manufacturing Tesma International, Inc. is used to manufacture engine, transmission and fueling components. Its engine productsuesd to include oil and water pumps, as well as pulleys and tensioners. Its transmission systems uesd to include torque converters and clutch housings. Its offerings uesd to include cap-to-tank refueling modules. It was located in Concord, Canada | Producer Manufacturing |
- Beurs
- Insiders
- Anthony Dobranowski
- Ervaring
